Neoadjuvant chemotherapy is increasingly used in breast cancer, especially for
downstaging the primary tumor in the breast and the metastatic axillary lymph node …

Neoadjuvant (primary systemic) treatment has become a standard option for primary
operable disease for patients who are candidates for adjuvant systemic chemotherapy …

Purpose: While various studies have highlighted the prognostic significance of pathologic
complete response (pCR) after neoadjuvant chemotherapy (NAT), the impact of additional …

Neoadjuvant chemotherapy (NAC) has become a widely accepted method of sequencing
systemic therapy for breast cancer treatment. While 'response to chemotherapy'in the …

Background A high neutrophil-to-lymphocyte ratio (NLR) may be related to increased
mortality in patients with lung, colorectal, stomach, liver, and pancreatic cancer. To date, the …

The androgen receptor (AR) has been shown to be of potential prognostic importance in
retrospective cohorts. We evaluated immunohistochemical AR expression on a tissue …

Purpose To determine whether residual ductal carcinoma in situ (DCIS) after completion of
preoperative chemotherapy affects the outcome of patients with histologically defined …

Context.—Currently, more women are being treated with chemotherapy or hormonal agents
before surgery (neoadjuvant chemoendocrine therapy) for earlier-stage operable breast …

BACKGROUND. This study investigated the role of magnetic resonance imaging (MRI) in
evaluation of pathologically complete response and residual tumors in patients who were …

Background Neoadjuvant chemotherapy (NAC) is one of the main strategies for patients with
locally advanced breast cancer. In recent years several biological markers such as estrogen …